Highlights Dr. Lal PathLabs Limited Bombay S.E.

Equities

LALPATHLAB

INE600L01024

Market Closed - Bombay S.E. Other stock markets 06:00:49 2024-04-29 am EDT			5-day change	1st Jan Change
2,349 ^INR	-1.60%		+3.63%	-8.76%

Apr. 26	Dr. Lal Pathlabs Limited Announces Resignation of Bharath U as Chief Executive Officer, Effective May 9, 2024	CI
Mar. 18	Dr Lal Pathlabs Names CEO	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dr. Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q3; EPS, Revenue Miss Estimates	Feb. 01	MT
Dr. Lal PathLabs Seeks M&A	Feb. 01	CI
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests	Feb. 01	RE
Dr. Lal PathLabs Limited Approves Second Interim Dividend for the Fiscal Year 2023-24	Feb. 01	CI
Dr. Lal PathLabs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 01	CI
Dr. Lal Pathlabs Board to Consider Second Interim Dividend for Fiscal 2024	Jan. 25	MT
Dr Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q2; Shares Climb 5%	Nov. 03	MT
Dr. Lal PathLabs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 02	CI
Dr. Lal Pathlabs Limited Approves to Declare Final Dividend for the Financial Year Ended March 31, 2023	23-09-12	CI
Dr Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q1; Revenue Meets Estimates	23-07-31	MT
Dr. Lal PathLabs Seeks Inorganic Opportunity	23-07-27	CI
Dr. Lal Pathlabs Limited Proposes Interim Dividend for the Financial Year 2023-24	23-07-27	CI
Dr. Lal PathLabs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-27	CI
Dr. Lal PathLabs Limited acquired additional 10% stake in Aprl Pathlabs Private Limited.	23-07-26	CI
Dr. Lal PathLabs' Consolidated Net Profit Declines in Fiscal Q4; Shares Up 3%	23-05-12	MT
Dr. Lal Pathlabs' Consolidated Profit Drops in Fiscal Q4	23-05-11	MT
India's Dr. Lal PathLabs reports decline in Q4 profit	23-05-11	RE
Dr. Lal Pathlabs Limited Recommends Final Dividend for the Year Ended March 31, 2023	23-05-11	CI
Dr. Lal PathLabs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-11	CI
Dr Lal Path Labs to Consider Final Dividend for FY23	23-05-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Dr. Lal PathLabs Limited Bombay S.E.

Equities

LALPATHLAB

INE600L01024

Highlights

Filters